A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Epilepsy, Temporal Lobe

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

    Contact: Study coordinator (Shellah Rogers, Nurse) · Scrogers2@uams.edu · 501-398-8622
    Contact: Principal Investigator (Sisira Yadala, MD)
  • University of Southern California Keck Hospital, Los Angeles, California, United States

    Contact: Study coordinator (Zoe B Durkin, SC) · zoe.durkin@med.usc.edu · 323-422-6625
    Contact: Principal Investigator (Charles Y Liu, MD, PhD)
  • UC Irvine Medical Center, Orange, California, United States

    Contact: Study coordinator (UCI Alpha Clinic) · 949-824-3990
    Contact: Principal Investigator (Mona Sazgar, MD)
  • Stanford University, Palo Alto, California, United States

    Contact: Study coordinator (Jordan Seliger, CRC, MA) · jseliger@stanford.edu · 650-460-9260
    Contact: Principal Investigator (Kevin Graber, MD)
  • University of California San Diego, San Diego, California, United States

    Contact: Study coordinator (Mateo Santizo, CRC) · msantizo@health.ucsd.edu · (858)583-0929
    Contact: Principal Investigator (Jerry J Shih, MD)
  • University of California San Francisco, San Francisco, California, United States

  • University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States

    Contact: Study coordinator (Pamela D Gerecht, Ph.D. SC) · pamela.davidgerecht@cuanschutz.edu · 303-724-4134
    Contact: Principal Investigator (Steven Ojemann, MD)
  • University of Chicago, Chicago, Illinois, United States

    Contact: Study coordinator (Agnieszka Stadnik, MS) · astadnik@bsd.uchicago.edu · 773-702-8996
    Contact: Principal Investigator (Peter Warnke, MD)
  • University of Iowa Health Care, Iowa City, Iowa, United States

    Contact: Study coordinator (Loraine Brenner, MSN) · loraine-brenner@uiowa.edu · 319-356-4361
    Contact: Principal Investigator (Mark Granner, MD)
  • SUNY Upstate Medical University, Syracuse, New York, United States

    Contact: Study coordinator (Lena F Deb, BA) · debl@upstate.edu · 315-464-9756
    Contact: Principal Investigator (Shahram Izadyar, MD)
  • Atrium Health, Charlotte, North Carolina, United States

    Contact: Study coordinator (Dianelis Diaz, RN, BSN, CRC) · dianelis.diaz@atriumhealth.org · 704-446-1900
    Contact: Principal Investigator (Rajdeep Singh, MD)
  • Duke University Hospital, Durham, North Carolina, United States

    Contact: Study coordinator (Hazani Benitez-Rosas) · Hazani.benitez-rosas@duke.edu · 919-681-4974
    Contact: Principal Investigator (Derek Southwell, MD, PhD)
  • Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States

    Contact: Study coordinator (Carolyn W Hedrick, RMA, CCRP) · Carolyn.Hedrick@AdvocateHealth.org · 336-716- 8694
    Contact: Principal Investigator (Gautam S Popli, MD, MBA)
  • Oregon Health and Science University, Portland, Oregon, United States

    Contact: Study coordinator (Claire Dorfman, BA) · dorfman@ohsu.edu · 971-413-9201
    Contact: Principal Investigator (David C Spencer, MD)
  • UTHealth Houston, Houston, Texas, United States

    Contact: Study coordinator (Eliana M Klier, PhD) · Eliana.Klier@uth.tmc.edu · 713-500-5442
    Contact: Principal Investigator (Nitin Tandon, MD)
  • UVA Health University Medical Center, Charlottesville, Virginia, United States

    Contact: Study coordinator (Kimberlee E Meegan, BS, CRC III) · dxh5dv@uvahealth.org · 434-243-2040
    Contact: Principal Investigator (Nathan Fountain, MD)
  • Medical College of Wisconsin, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Sarah Young, MS) · scyoung@mcw.edu · 414-955-0989
    Contact: Principal Investigator (Sean Lew, MD)
Study leads
  • Eduardo Dunayevich, MD

    Study Director

    Neurona Therapeutics